NCT03342170View on ClinicalTrials.gov

Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis?

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

January 22, 2020

Conditions
Alcoholic or Viral C Compensated Cirrhosis
Interventions
GENETIC

G20210A prothrombin gene mutation and Factor 5 Leiden mutation

blood sample

Trial Locations (1)

14033

CHU de CAEN, Caen

All Listed Sponsors
collaborator

Thong DAO

UNKNOWN

collaborator

Annie BOREL-DERLON

UNKNOWN

collaborator

Nathalie GANNE-CARRIE

UNKNOWN

collaborator

Pierre NAHON

UNKNOWN

collaborator

Sylvie CHEVRET

UNKNOWN

lead

University Hospital, Caen

OTHER

NCT03342170 - Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis? | Biotech Hunter | Biotech Hunter